BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2186336)

  • 1. The measurement of DNA content and ploidy analysis in thyroid neoplasms.
    McLeod MK
    Otolaryngol Clin North Am; 1990 Apr; 23(2):271-90. PubMed ID: 2186336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
    Lanza G; Maestri I; Dubini A; Gafà R
    Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
    Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
    Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow-cytometric DNA ploidy analysis in primary and metastatic canine thyroid carcinomas.
    Verschueren CP; Rutteman GR; Kuipers-Dijkshoorn NJ; Sjollema BE; Vos JH; van Dijk JE; Cornelisse CJ
    Anticancer Res; 1991; 11(5):1755-61. PubMed ID: 1768049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
    Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
    Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA cytophotometry of oxyphilic thyroid tumors].
    Pilch H; Back W; Winter J
    Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of nuclear DNA content in benign and malignant thyroid lesions.
    Konarska L; Skierski J; Ellert A; Steinbrich J; Woźniak A; Kalczak M
    Acta Biochim Pol; 2001; 48(3):783-93. PubMed ID: 11833787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
    Lukács GL; Balázs G; Zs-Nagy I; Mikó T
    Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Image analysis DNA cytometry in medullary thyroid gland cancer. Comparison with histomorphologic parameters and prognostic effect].
    Böttger T; Potratz D; Gabbert H; Schernus B; Stöckle M; Klupp J; Junginger T
    Chirurg; 1993 Feb; 64(2):122-9. PubMed ID: 8096455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
    Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
    Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.